AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


HPV Testing Update: Understanding New Guidelines, Assessing New Technology

HPV Testing Update
  • Copyright: 2012
  • Speaker: Mark Stoler and Frederick Nolte

Price: $119.00

Member Price: $99.00

Rating: Member Average

This is a recorded version of the AACC webinar, HPV Testing Update: Understanding New Guidelines, Assessing New Technology, which was originally held August 28, 2012. During this program, experts discuss what the current guidelines for cervical cancer screening are and how they predict risk; the major applications of HPV testing and the role it plays in these guidelines; what it means to have a clinically validated HPV test; the advantages and limitations of using today's FDA-cleared HPV testing technologies; why traditional method validation protocols won't work with new HPV testing technologies; and how to handle sampling issues specific to various HPV testing methods.

Target Audience:

Laboratory administrators, directors, and managers; cytopathologists; molecular pathologists; clinicians; and IVD industry professionals involved in cervical cancer screening or HPV testing.